Cadence
Device Extremity, Lower Total Ankle
PDI 10381780530152
General payments
$2,183,560
Research payments
$93,131
Through program year 2025, $2,183,560 in general payments and $93,131 in research payments were reported against Cadence (Extremity, Lower Total Ankle).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $351,564 | 208 |
| 2025 | Research | $15,105 | 6 |
| 2024 | General | $330,462 | 176 |
| 2024 | Research | $32,584 | 8 |
| 2023 | General | $524,764 | 420 |
| 2023 | Research | $27,658 | 11 |
| 2022 | General | $603,216 | 595 |
| 2022 | Research | $9,805 | 2 |
| 2021 | General | $373,554 | 409 |
| 2021 | Research | $7,979 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,808 general · 30 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.